Skip to content

Examining Transcutaneous Vagal Nerve Stimulation as a Facilitator of Social Bonding

Examining Transcutaneous Vagal Nerve Stimulation as a Facilitator of Social Bonding

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05899413
Acronym
CtVNS
Enrollment
160
Registered
2023-06-12
Start date
2024-02-17
Completion date
2024-07-31
Last updated
2025-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vagus Nerve Stimulation

Brief summary

This study aims to understand the role of the vagus nerve in promoting social bonding by using a non-invasive stimulation technique called transcutaneous vagal nerve stimulation (tVNS). The investigators will investigate whether tVNS can improve emotional, physiological, and behavioral experiences during and after social interactions. Couples will be randomly assigned to receive either tVNS or a sham stimulation during gratitude expression and problem-solving discussions. The investigators will measure their subjective evaluations of the interactions and capture their physiological and behavioral synchrony. This research will shed light on the processes involved in social connection and explore the potential of tVNS as a tool to enhance bonding in close relationships.

Detailed description

As fundamental as the need to belong is to human survival and functioning, decades of research have shown that social connection is critical to emotional well-being. The current investigation seeks to use the knowledge and technological advances in the biomedical field to examine the causal role of the vagus nerve in promoting social bonding. Specifically, building on the recent evidence suggesting the effects of transcutaneous vagal nerve stimulation (tVNS) on improving social cognitive functioning, this study will examine the utility of tVNS in modulating emotional, physiological, and behavioral experiences during and after social interactions. The investigators will examine if romantic couple assigned to receive tVNS vs. active sham stimulation during two types of conversations (i.e., gratitude expression and problem-solving discussion) show differences in their experiences of the interactions. The study outcomes will include subjective evaluations of the interaction (e.g., felt emotions) and their physiological synchrony. This investigation will provide insights into the mechanistic processes that undergird social connection and, importantly, be the first to examine the potential utility of tVNS as an intervention tool for promoting social bonding within close relationships.

Interventions

The intervention consists of neurostimulation device that is programmed to a stimulus intensity at 0.5mA with a stimulation frequency of 25 Hz at the outer auditory canal.

Sponsors

National Institute on Aging (NIA)
CollaboratorNIH
University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Masking description

Participant couples will be blinded to their condition. Experimenters running the study will not be blinded since tVNS administration currently requires their knowledge of the condition.

Intervention model description

Couple dyads will be randomly assigned to receive either tVNS or sham stimulation.

Eligibility

Sex/Gender
ALL
Age
18 Years to 39 Years
Healthy volunteers
Yes

Inclusion criteria

* Fluent in English * Having been in a relationship with the partner for at least a year * Within the age range of 18-39

Exclusion criteria

* Major chronic disease. self-reported autoimmune disease; severe asthma; lung disease (such as chronic bronchitis; history of stroke, heart attack, epilepsy, brain injury); cardiovascular disease. * Cancer: if not in remission. * Substance dependence-current or long history (5 years of more). * Current psychiatric diagnosis that is not being treated with medication * Confounding medications, including those used to treat hypertension and cardiovascular conditions; psychoactive substances; and medications known to directly affect autonomic functioning.

Design outcomes

Primary

MeasureTime frameDescription
Self-reported Positive AffectOnce, self-reported in a survey immediately following conflict interaction, up to 10 minutesDuring the conversation, overall, I felt… (1: not at all positive, 7: extremely positive)
Self-reported Negative AffectOnce, self-reported in a survey immediately following conflict interaction, up to 10 minutesDuring the conversation, overall, I felt… (1: not at all negative, 7: extremely negative)
Respiratory Sinus ArrhythmiaContinuously throughout conflict conversationRSA was assessed continuously throughout the conversation.
Interbeat IntervalContinuously throughout the conflict conversationIBI was assessed continuously throughout the conversation.

Countries

United States

Participant flow

Recruitment details

A total of 80 couples (i.e., 160 participants) were recruited from February 2024.

Pre-assignment details

Couples were randomly assigned to either the active or sham stimulation condition after confirming their eligibility and completing a background questionnaire at home. Although all sessions were completed, technical issues (e.g., tVNS device malfunction) occurred in some cases. When this happened, the affected couple was excluded from the random assignment, and the next couple was reassigned to that condition.

Participants by arm

ArmCount
Active tVNS
We delivered stimulation at the individually calibrated intensity continuously during the interactions, and the default device settings we adopted were as follows: frequency = 30Hz, phase duration = 250μs, interphase interval = 50μs, and max voltage = 65V. In the active stimulation condition, both partners will have the stimulation clip attached to the outer auditory canal.
63
Sham tVNS
In the sham condition, both partners will have electrodes attached to the center of the left ear lobe. They will still receive stimulation but at a placement that should not activate the vagus nerve.
71
Total134

Baseline characteristics

CharacteristicActive tVNSSham tVNSTotal
Age, Continuous28.17 years
STANDARD_DEVIATION 4.33
27.65 years
STANDARD_DEVIATION 4.26
27.90 years
STANDARD_DEVIATION 4.29
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants2 Participants3 Participants
Race (NIH/OMB)
Asian
27 Participants35 Participants62 Participants
Race (NIH/OMB)
Black or African American
0 Participants3 Participants3 Participants
Race (NIH/OMB)
More than one race
1 Participants4 Participants5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants4 Participants5 Participants
Race (NIH/OMB)
White
33 Participants23 Participants56 Participants
Relationship duration4.23 Years
STANDARD_DEVIATION 3.06
4.41 Years
STANDARD_DEVIATION 2.41
4.33 Years
STANDARD_DEVIATION 2.73
Sex/Gender, Customized
Female/Male/Other
Female
30 Participants34 Participants64 Participants
Sex/Gender, Customized
Female/Male/Other
Male
32 Participants34 Participants66 Participants
Sex/Gender, Customized
Female/Male/Other
Other
1 Participants3 Participants4 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 00 / 0
other
Total, other adverse events
0 / 1600 / 160
serious
Total, serious adverse events
0 / 00 / 0

Outcome results

Primary

Interbeat Interval

IBI was assessed continuously throughout the conversation.

Time frame: Continuously throughout the conflict conversation

Population: Our analysis included 134 participants with complete physiological and self-report data. Missing data resulted from session failures (e.g., unstable or missing physiological measurements) or survey non-response

ArmMeasureValue (MEAN)Dispersion
Active tVNSInterbeat Interval793.71 msStandard Deviation 101.74
Sham tVNSInterbeat Interval808.20 msStandard Deviation 100.63
Primary

Respiratory Sinus Arrhythmia

RSA was assessed continuously throughout the conversation.

Time frame: Continuously throughout conflict conversation

Population: Our analysis included 134 participants with complete physiological and self-report data. Missing data resulted from session failures (e.g., unstable or missing physiological measurements) or survey non-response

ArmMeasureValue (MEAN)Dispersion
Active tVNSRespiratory Sinus Arrhythmia6.47 msStandard Error 0.74
Sham tVNSRespiratory Sinus Arrhythmia6.54 msStandard Error 0.89
Primary

Self-reported Negative Affect

During the conversation, overall, I felt… (1: not at all negative, 7: extremely negative)

Time frame: Once, self-reported in a survey immediately following conflict interaction, up to 10 minutes

Population: Our analysis included 134 participants with complete physiological and self-report data. Missing data resulted from session failures (e.g., unstable or missing physiological measurements) or survey non-response

ArmMeasureValue (MEAN)Dispersion
Active tVNSSelf-reported Negative Affect5.79 units on a scaleStandard Deviation 1.18
Sham tVNSSelf-reported Negative Affect5.62 units on a scaleStandard Deviation 1.32
Primary

Self-reported Positive Affect

During the conversation, overall, I felt… (1: not at all positive, 7: extremely positive)

Time frame: Once, self-reported in a survey immediately following conflict interaction, up to 10 minutes

Population: Our analysis included 134 participants with complete physiological and self-report data. Missing data resulted from session failures (e.g., unstable or missing physiological measurements) or survey non-response

ArmMeasureValue (MEAN)Dispersion
Active tVNSSelf-reported Positive Affect5.89 units on a scaleStandard Deviation 0.92
Sham tVNSSelf-reported Positive Affect5.69 units on a scaleStandard Deviation 1.15

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026